Results 241 to 250 of about 5,464,336 (251)

Exploring the educational needs for severe immune-related adverse events of PD-1/PD-L1 inhibitors in advanced lung cancer: A single-center observational study

Asia-Pacific Journal of Oncology Nursing, 2022
Toshiaki Takahashi, Shota Omori, Haruyasu Murakami   +2 more
exaly  

Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin’s lymphoma (B-NHL) chemotherapy: a meta-analysis

Journal of Chemotherapy, 2015
Hu Liu, Yanzhe Zhu
exaly  

Adverse Events Associated with High-Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome

Pharmacotherapy, 2007
Allison McGeer, Janet Raboud, Tony Mazzulli   +2 more
exaly  

Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis

International Immunopharmacology, 2018
Zuzhen Ou
exaly  

Treatment related severe and fatal adverse events with cetuximab in colorectal cancer patients: a meta-analysis

Journal of Chemotherapy, 2013
Junjie Ye, Tangpeng Xu
exaly  

Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience

Expert Review of Vaccines, 2018
Matthew Boulton, Jyoti Joshi
exaly  

Nurse workload and inexperienced medical staff members are associated with seasonal peaks in severe adverse events in the adult medical intensive care unit: A seven-year prospective study

International Journal of Nursing Studies, 2016
Pierre Durieux, Christophe Faisy, Maxime Esvan   +2 more
exaly  

Single nucleotide polymorphisms in long noncoding RNA, ANRIL, are not associated with severe periodontitis but with adverse cardiovascular events among patients with cardiovascular disease

Journal of Periodontal Research, 2018
Susanne Schulz, A Schlitt, H -G Schaller
exaly  

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

Annals of Oncology, 2019
Gregory J Riely, Adam Schoenfeld, Matthew D Hellmann   +2 more
exaly  

People also looked at

Frontiers in Oncology
Maéva ZYSMAN, Fanny Duval, Rémi Veillon   +2 more
exaly